Caina Xu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Caina Xu has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Chang Liu
Department of Neurology and Neuroscience Centre, First Hospital of Jilin University, Changchun, 130021, China
1 shared publication Heshi Liu
Department of Gastrocolorectal Surgery, General Surgery Center, The First Hospital of Jilin University, Changchun 130021, China
1 shared publicationHongtao Liu
The Second Hospital for Veterans of Jilin Province, Siping 136502, China
1 shared publication- Huayu Tian
Xiamen University
1 shared publication Mujie Kan
College of Basic Medical Sciences, the Medical Basic Research Innovation Centre of Airway Disease in North China, Key Laboratory of Pathobiology, Ministry of Education, Jilin University, Changchun, 130021, China
1 shared publicationPai Wang
Department of Gastrocolorectal Surgery, General Surgery Center, The First Hospital of Jilin University, Changchun 130021, China
1 shared publication
Latest Publications
- Open Access
- 9 January 2026
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 62 (22) , 6192-6195
A pH-responsive iron/manganese bimetallic organic framework nanosystem for synergistic therapy of colon cancer
The release of MTO from FMMS NPs further exerted its chemotherapeutic effects and, in conjunction with ferroptosis, induced immunogenic cell death.
- 9 January 2026
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 62 (22) , 6192-6195
Open AccessA pH-responsive iron/manganese bimetallic organic framework nanosystem for synergistic therapy of colon cancer
The release of MTO from FMMS NPs further exerted its chemotherapeutic effects and, in conjunction with ferroptosis, induced immunogenic cell death.
- 20 August 2025
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 13 (19) , 5325-5351
Application of metal–organic framework-based reactive oxygen species therapy in cancer
This review highlights the application of metal–organic frameworks (MOFs) in reactive oxygen species (ROS)-mediated cancer therapy, offering critical insights into design strategies and therapeutic potential.
- 20 August 2025
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 13 (19) , 5325-5351
Application of metal–organic framework-based reactive oxygen species therapy in cancer
This review highlights the application of metal–organic frameworks (MOFs) in reactive oxygen species (ROS)-mediated cancer therapy, offering critical insights into design strategies and therapeutic potential.